News
Director of Health and Science Policy at Citizens Against Government Waste Calls Drug Importation Dangerous
Instead of wasting time and money on dangerous and faulty importation proposals, Congress should encourage the FDA to speed up the drug approval process and reduce the cost of program and application fees for future drug development. In 2022, the application fee for a human drug application will cost $1.6 million for drugs that don’t require clinical data and $3.1 million for medicines that do need clinical data.
[...]June 6, 2022: San Diego doctor sentenced for COVID treatment fraud
In this week’s news: A San Diego doctor pays for smuggling hydroxychloroquine to sell fake $4,000 COVID treatment kits; the British Medical Journal writes about black market sales of molnupiravir; Canadians warn about fake Xanax made with flualprazolam; and 14 more stories in 11 states.
[...]Drug Importation Is Not The Solution Americans Need
While working to find a way to provide relief to patients at the pharmacy counter, American politicians again look to the idea of drug importation as a possible solution. Looking at all the evidence, the Partnership for Safe Medicines believes such plans will not only make no difference in reducing patient out-of-pocket costs, but will…
[...]Congress: Don’t invite global drug counterfeiters to the U.S. Drug Supply
Watch our new ad: “Congress: Don’t invite global drug counterfeiters to the U.S. Drug Supply” As the pandemic upended our daily lives, illegally-imported counterfeit products flooded into our communities. Criminals all over the world moved quickly to exploit fear and take advantage of disrupted supply lines in March 2020. Americans were—and continue to be—deluged in…
[...]May 31, 2022: PSM holds online congressional briefing about drug importation
PSM holds its 2022 congressional briefing. A study of FDA enforcement actions underscores the real threat of fake drugs; a New York pharmacy-owner who allegedly sold fake HIV drugs is sentenced in a different crime; large amphetamine pill seizures in Montreal and Jordan; and stories relating to pressed counterfeit pills in 16 states.
[...]Video: Report Ignored (Still no action on drug dealing Facebook page)
Trafficking pharmaceuticals or illicit drugs violates Facebook’s community guidelines, but drug dealers are advertising them on Facebook anyway–even after they’ve been reported. Watch to learn more.
[...]May 23, 2022: “ISO” found in DC-area counterfeit pills, says DEA
In this week’s news: counterfeit pills made with isotonitazene in the DC-area; Drug resistant malaria and a prescription drug bust in Africa; a former health minister goes to prison over fake medicines in Vietnam; and news about pressed pills in 15 states.
[...]May 16, 2022: More than 107,000 U.S. drug deaths in 2021
The CDC releases preliminary data suggesting that drug deaths climbed 15% in 2021; the DEA reports on fentanyl precursor seizures and 28 more stories cover deaths, seizures and prosecutions across the country.
[...]FDA Alert: Class 1 Recall of Some Mesa Biotech COVID Tests Due to Risk of False Positives/Contamination
This is a reprint of an FDA Alert. Mesa Biotech, Inc., Recalls Certain Accula SARS-CoV-2 Tests for Risk of False Positives Caused by Contamination The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. Recalled Product Product Name: Accula…
[...]FDA Alert: Class 1 Recall on Skippack Medical Lab SARS-CoV-2 Antigen Rapid Test
This is a reprint of an FDA Alert. Do Not Use Skippack Medical Lab SARS-CoV-2 Antigen Rapid Test: FDA Safety Communication May 10, 2022 The U.S. Food and Drug Administration (FDA) is warning people not to use the Skippack Medical Lab SARS-CoV-2 Antigen Rapid Test (Colloidal Gold). This test is not authorized, cleared, or approved…
[...]